Associate Professor of Medicine, Massachusetts General Hospital
Cardiology
Dr. Marc J. Semigran, MD
|
|
Give Review
Marc Semigran is an expert in the field of Cardiology. He attended Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He received 1 awards: "Regional Top Doctor". Dr. Marc J. Semigran is also published. He has 51 publications published. The lastest publication: "Clinical Features and Outcomes in Adults With Cardiogenic Shock Supported by Extracorporeal Membrane Oxygenation.' Marc J. Semigran, MD accepts Medicare.
Publications
- Clinical Features and Outcomes in Adults With Cardiogenic Shock Supported by Extracorporeal Membrane Oxygenation.
- Cofilin-2 Phosphorylation and Sequestration in Myocardial Aggregates: Novel Pathogenetic Mechanisms for Idiopathic Dilated Cardiomyopathy.
- Serum free light chain trends between orthotopic Heart transplantation and auto-SCT in patients with AL amyloidosis.
- Weight loss, saline loading, and the natriuretic peptide system.
- Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Predictors of Survival to Orthotopic Heart Transplant in Patients with Light Chain Amyloidosis.
- Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.
- Riociguat for patients with Pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-rang...
- Prolonged Mean VO2 Response Time in Systolic Heart Failure: An Indicator of Impaired Right Ventricular-Pulmonary Vascular Function.
- Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in Heart failure with preserved ejection fraction: a randomized clinical trial.
- Characterization and Prediction of Natriuretic Peptide "Nonresponse" During Heart Failure Management: Results From the ProBNP Outpatient Tailored Chronic Heart Failure...
- Improvement in structural and functional echocardiographic parameters during chronic Heart failure therapy guided by natriuretic peptides: mechanistic insights from th...
- Heart Failure Outcomes and Benefits of NT-proBNP-Guided Management in the Elderly: Results From the Prospective, Randomized ProBNP Outpatient Tailored Chronic Heart Fa...
- Relationship of right- and left-sided filling pressures in patients with advanced Heart failure: A 14-year multi-institutional analysis.
- Use of amino-terminal pro-B-type natriuretic Peptide to guide outpatient therapy of patients with Chronic left ventricular systolic dysfunction.
- Exercise Oscillatory Ventilation in Systolic Heart Failure: An Indicator of Impaired Hemodynamic Response to Exercise.
- Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in Pulmonary arterial hypertension.
- Pulmonary Vascular Response Patterns During Exercise in Left Ventricular Systolic Dysfunction Predict Exercise Capacity and Outcomes.
- Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels.
- Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and Heart failure.
- Metabolic signatures of exercise in human plasma.
- Heart failure and pulmonary hypertension.
- Protein aggregates and novel presenilin gene variants in idiopathic dilated Cardiomyopathy.
- Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway.
- Patient expectations from implantable defibrillators to prevent death in Heart failure.
- Thresholds of physical activity and life expectancy for patients considering destination ventricular assist devices.
- Pulmonary hypertension secondary to left ventricular systolic dysfunction: contemporary diagnosis and management.
- Phosphodiesterase type 5 inhibition: a support of the left ventricular assist device bridge to transplant.
- Determinants of ventilatory efficiency in Heart failure: the role of right ventricular performance and pulmonary vascular tone.
- Human cardiac-specific cDNA array for idiopathic dilated Cardiomyopathy: sex-related differences.
- Case records of the Massachusetts General Hospital. Case 37-2007. A 47-year-old man with left ventricular dysfunction after Heart transplantation.
- Sildenafil improves exercise capacity and quality of life in patients with systolic Heart failure and secondary pulmonary hypertension.
- Elevated estimated pulmonary Artery systolic pressure is associated with an adverse clinical outcome in patients receiving cardiac resynchronization therapy.
- Analysis of cardiac dimensions, mass and function in Heart transplant recipients using 64-slice multi-detector computed tomography.
- Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic Heart failure.
- Comparison of sixty-four-slice multidetector computed tomographic Coronary angiography to Coronary angiography with intravascular ultrasound for the detection of trans...
- The emerging role for type 5 phosphodiesterase inhibition in Heart failure.
- Sildenafil improves Coronary artery patency in a canine model of platelet-mediated cyclic Coronary occlusion after thrombolysis.
- Combined administration of intraVenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant...
- Type 5 phosphodiesterase inhibition: the focus shifts to the Heart.
- Hemodynamic effects of sildenafil in patients with congestive Heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
- Catheter ablation of atrial flutter after orthotopic Heart transplantation.
- Type 5 phosphodiesterase inhibition in Heart failure and pulmonary hypertension.
- Hemodynamic effects of inhaled nitric oxide in right ventricular Myocardial infarction and cardiogenic shock.
- Pulmonary thromboEmbolism superimposed on a congenital ventricular septal defect in a 50-year-old man inhaled nitric oxide and sildenafil to the rescue.
- Right-to-left shunting through a patent foramen ovale in right ventricular Infarction: improvement of hypoxemia and hemodynamics with inhaled nitric oxide.
- Left ventricular diastolic function in patients with advanced cystic fibrosis.
- Effect of sildenafil on the Acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension.
- Tricuspid Regurgitation and Right Heart Dimensions at Early and Late Follow-Up After Orthotopic Cardiac Transplantation.
Schools
Harvard Medical School
Massachusetts General Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1063482602 | |
| NPPES Provider LastName | SEMIGRAN | |
| NPPES Provider FirstName | MARC | |
| NPPES Provider ZIPCode | 021142696 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 867.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063482602 |
| Last Name Of The Provider | SEMIGRAN |
| First Name Of The Provider | MARC |
| View All |
Similar Doctors
|
|
Dr. Susie N. Hong-Zohlman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ignacio Inglessis-Azuaje, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katarina H. Nelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric A. Osborn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dominic J. Allocco, MD |
|
|
Dr. Stafford I. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sean Wilson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brendan M. Everett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodney H. Falk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amer Johri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Denofrio, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gary Huang, MD |